Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3 Allylindole Derivatives. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112876401A discloses a mild, one-step iridium-catalyzed synthesis of chiral 3-allylindoles with high enantioselectivity, offering cost-effective solutions for pharmaceutical manufacturing.
Patent CN116478081A reveals novel monodentate phosphine ligands for palladium-catalyzed asymmetric allylation. Achieve high enantioselectivity and yield for reliable pharmaceutical intermediate supply chains.